ERBB2 and breast cancer: (84) revealed that overexpression of METTL3, METTL14, FTO, and ALKBH5, and under-expression WTAP was closely related with luminal type breast cancer, while the expression level of FTO was significantly decreased in human epidermal growth factor receptor 2 (HER2) positive breast cancer.